These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 6256875

  • 1. [Cross-over study of benfluorex and a hypolipemic agent in diet-resistant types IV and II b hyperlipemia (author's transl)].
    Graisely B, Cloarec M.
    Sem Hop; ; 56(25-28):1221-5. PubMed ID: 6256875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
    Sznajderman M.
    Przegl Lek; 1984; 41(7):493-9. PubMed ID: 6390536
    [No Abstract] [Full Text] [Related]

  • 4. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
    Altomonte L, Mingrone G, Ghirlanda G, Manna R, Rebuzzi A, Pala MA, Greco AV.
    Minerva Med; 1980 Feb 11; 71(4):273-8. PubMed ID: 7354946
    [Abstract] [Full Text] [Related]

  • 5. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J, Martorell J.
    Clin Ther; 1980 Feb 11; 3(4):234-41. PubMed ID: 7273061
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ, Gutiérrez JA, Menéndez JA, Micó L, Muñoz M, de Oya M.
    Clin Ther; 1980 Feb 11; 3(3):219-26. PubMed ID: 7459931
    [Abstract] [Full Text] [Related]

  • 8. Effects of benfluorex in obese patients with metabolic disorders.
    di Martino G, Federico P, Mattera E, Jacono G.
    Br J Clin Pract; 1989 Jun 11; 43(6):201-8. PubMed ID: 2597599
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
    Bonora V, Calalabuig RJ, Caviola E, Soler J, Pueyo JM, Micaló T, Cano RP.
    Clin Ther; 1981 Jun 11; 4(3):192-200. PubMed ID: 7030489
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
    Vorberg G, Ziegler WJ.
    Arzneimittelforschung; 1980 Jun 11; 30(11b):2068-72. PubMed ID: 7194062
    [Abstract] [Full Text] [Related]

  • 13. Gemfibrozil--a new lipid lowering agent.
    Nash DT.
    J Med; 1980 Jun 11; 11(2-3):107-16. PubMed ID: 6931871
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.